Related Experiment Video
Updated: May 15, 2025
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Therapeutic effect of miR-30b-5p-loaded lentivirus on experimental autoimmune uveitis via inhibiting Notch signaling
Xuewei Yin1,2,3, Huixia Wei2, Lijie Guo4
1Shandong University of Traditional Chinese Medicine, Jinan, 250002, China.
Background:
Uveitis is a common recurrent autoimmune disease that seriously endangers the visual health of patients. MicroRNAs (miRNAs) are closely related to a series of autoimmune diseases.
Methods:
The present study aimed to investigate the effect of miR-30b-5p on experimental autoimmune uveitis (EAU) and its role in Notch signal activation as well as T helper (Th) cell differentiation, the relationship between miR-30b-5p levels and Notch signal activation, as well as Th cell differentiation in uveitis was further explored through flow cytometry, Immunohistochemistry immunofluorescence staining, PCR Array, and Ingenuity Pathway Analysis, and other technical methods to determine the fidelity of miR-30b-5p strategies in treating uveitis in vivo and in vitro.
Results:
We demonstrated that ocular inflammation was significantly alleviated in EAU rats after miR-30b-5p intervention. miR-30b-5p could effectively inhibit Notch signaling activation and Th17 cell differentiation both in vitro and in vivo, and the Th17/Treg ratios were also notably decreased. Moreover, both Notch signaling and Th17 activation pathways were enriched and activated, in which Notch1 was the upstream regulatory molecule of Dll4 and IL-10 was an up-regulated upstream regulatory network molecule. Furthermore, miR-30b-5p could significantly reduce apoptosis in vitro, and clinical in vitro cell studies have shown that inactivating Notch pathway can improve the imbalance of Th17/Treg and cell apoptosis in T lymphocytes of patients with uveitis.
Conclusions:
Together these studies identify that miR-30b-5p can significantly inhibit Notch signaling activation and Th17 cell differentiation, thereby restoring the Th17/Treg balance to treat uveitis, which may provide new insights into treating uveitis using miRNA interfering strategies.
Insights
MicroRNA-30b-5p effectively treats uveitis by inhibiting Notch signaling and Th17 cell differentiation, restoring immune balance. This discovery offers new therapeutic strategies for autoimmune eye diseases.
Area of Science:
- Immunology
- Ophthalmology
- Molecular Biology
Background:
- Uveitis is a recurrent autoimmune disease impacting vision.
- MicroRNAs (miRNAs) are implicated in autoimmune disease pathogenesis.
Purpose of the Study:
- Investigate miR-30b-5p's effect on experimental autoimmune uveitis (EAU).
- Determine miR-30b-5p's role in Notch signaling and T helper (Th) cell differentiation.
- Explore the relationship between miR-30b-5p, Notch signaling, and Th cell differentiation in uveitis.
Main Methods:
- In vivo and in vitro studies using EAU rat models.
- Flow cytometry, immunohistochemistry, immunofluorescence staining.
- PCR Array and Ingenuity Pathway Analysis.
Main Results:
- miR-30b-5p intervention significantly reduced ocular inflammation in EAU rats.
- miR-30b-5p inhibited Notch signaling and Th17 cell differentiation, decreasing Th17/Treg ratios.
- Inactivated Notch pathway improved Th17/Treg imbalance and reduced T lymphocyte apoptosis in uveitis patients.
Conclusions:
- miR-30b-5p inhibits Notch signaling and Th17 differentiation, restoring Th17/Treg balance for uveitis treatment.
- This suggests potential miRNA-based therapeutic strategies for uveitis.
